Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vistin Pharma Major Shareholding Notification 2021

Oct 29, 2021

3782_mrq_2021-10-29_1d8662b9-b0b2-4c2d-b4af-2ae81279f8d0.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Vistin Pharma ASA: Disclosure of large shareholding

Vistin Pharma ASA: Disclosure of large shareholding

Pactum AS has on 29 October 2021 sold 3,519,733 shares in Vistin Pharma ASA (the "Issuer"), corresponding to 7.9% of the issued and outstanding shares and votes in the Issuer, at NOK 19.50 per share, to its wholly-owned subsidiary Pactum Vekst AS in connection with an internal reorganization of Pactum AS.

Following the transaction, (i) Pactum AS owns nil shares and votes in the Issuer and (ii) Pactum Vekst AS owns 3,519,733 shares in the Issuer, corresponding to 7.9% of the issued and outstanding shares and votes in the Issuer.